Recorded Chinese product: 盐酸洛贝林注射液盐酸洛贝林注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 北京市永康药业有限公司Chinese legal name: 北京市永康药业有限公司
主要成分Active Ingredients
- 洛贝林Luobei Lin
药物知识说明
洛贝林是一种在国家药监局注册认定的药品。该药品含有洛贝林-034af283等成分。
该药品关联的活性成分包括：洛贝林Luobei Lin。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：北京市永康药业有限公司Chinese legal name: 北京市永康药业有限公司。
您可以探索含有相同成分的其他药品：洛贝林-034af283成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 盐酸洛贝林注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 洛贝林Luobei Lin.
Manufacturers recorded for this product: 北京市永康药业有限公司Chinese legal name: 北京市永康药业有限公司.
Explore other medicines containing the same ingredient: 洛贝林 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 盐酸洛贝林注射液Recorded Chinese product: 盐酸洛贝林注射液
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 1ml：3mg1 mL:3 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 北京市永康药业有限公司Chinese legal name: 北京市永康药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H11020525
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H11020525
Manufacturer
Chinese legal name: 北京市永康药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H11020525
生产企业
北京市永康药业有限公司(国产)
适应症
本品主要用于各种原因引起的中枢性呼吸抑制。临床上常用于新生儿窒息，一氧化碳、阿片中毒等。
用法用量
1.静脉注射常用量：成人一次3mg(1支)；极量：一次6mg(2支)，一日20mg(约7支)。小儿一次0.3-3mg(1/10支-1支)，必要时每隔30分钟可重复使用；新生儿窒息可注入脐静脉3mg(1支)。2.皮下或肌内注射常用量：成人一次10mg(约3支)；极量：一次20mg(约7支)，一日50mg(约17支)。小儿一次1-3mg(1/3支-1支)。
不良反应
可有恶心、呕吐、呛咳、头痛、心悸等。
禁忌
尚不明确
注意事项
剂量较大时，能引起心动过速、传导阻滞、呼吸抑制甚至惊厥。
贮藏
遮光，密闭保存。
规格
1ml：3mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.